Microarrays | Contrive Datum Insights

The Global Microarrays Market size was estimated at USD 3.72 Billion in 2022 and is expected to surpass USD 8.15 Billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030.

Microarrays Market Overview:

Microarray analysis is a way of examining sample DNA and RNA according to pairing rules using a gene chip. Millions of probes are arranged on a rigid surface forming a gene chip. This microarray measures the concentration of mRNA. Microarray analysis allows biological and numerical assumptions to be made.

This report provides a microarray of quantitative and qualitative analysis to help readers develop business/growth strategies, assess the market competitive landscape, analyze their current position in the market, and make informed business decisions. aims to provide a comprehensive presentation of the global market Regarding microarrays.

Factors like the growing prevalence of chronic diseases, the cost-effective nature of microarrays, easy accessibility, and standardization are driving market growth. Additionally, the rapid development of NGS is expected to hamper the growth of the market.

Microarray market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Microarray market in detail. Regional market sizes related to products by type, by application, and by the player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• Oct 16, 2018: Thermo Fisher Scientific custom microarrays drive large-scale genotyping studies in the Finnish population
  Thermo Fisher Scientific announced today that it is accelerating the next step in FinnGen precision medicine research, which aims to deepen our overall understanding of the mechanisms of chronic disease in the Finnish population and enable the development of targeted therapeutics. The latest phase focuses on analyzing more than 50,000 samples in 6 months to achieve the overall goal of 500,000 individual samples with Thermo Fisher's custom microarray technology.

Major Market Segments Covered in Microarray Industry Research:

Market Key Players:
Thermo Fisher Scientific,  Agilent, Sequenom, Roche NimbleGen, Illumnia, Applied Microarrays, BioMerieux  SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, ProteoGenix, And Others.

By Type:

• DNA Microarrays
• MM Chips
• Protein Microarrays
• Peptide Microarrays
• Tissue Microarrays
• Cellular Microarrays
• Other  

In 2020, the DNA microarray segment leads the microarray assay market in terms of revenue. DNA Microarray is used to diagnose pathogens or genetic diseases. DNA microarrays are also used in the development of new drugs and medicines. DNA microarrays can detect variations in SNP genotypes.

By Product: 

• Consumables 
• Software and services 
• Instruments

By End-Use:

• Research & Academic Institutes
• Pharmaceutical & Biotechnology Companies 
• Diagnostic Laboratories  Other End Users

By Application:

• Drug Discovery
• Diagnostics
• Genomic
• Proteomics
• Other

The Drug Discovery segment ruled the microarray market in 2021. Microarray technology has an extensive range of applications in Pharmacogenomics. The field of pharmacogenomics consists of comparative analysis of genes in diseased and normal cells that will help determine the biochemical makeup of proteins. This segment is expected to grow at a CAGR of 6.73% over the period under consideration.

By Region:

The microarray analysis market is dominated in the Americas due to the adoption of advanced diagnostic technology, awareness among people for better diagnostics, and large investments in research. The National Cancer Institute received USD 5.665 million from the Congress of the States for cancer research programs in 2018.

Europe is estimated to have ranked second in the global microarray analysis market. The increasing focus on drug discovery, personalized medicines, and targeted therapies is driving market growth in this region. In November 2016, more than 30 European and international members together with the European Commission established an initiative called the International Consortium for Personalized Medicine, or "ICPerMed" to establish Europe as a world leader in personalized medicine research. Thus, the growing research in personalized medicines serves as a favorable framework for the growth of the market in this region.

The microarray analysis market in Asia-Pacific is expected to experience growth due to the increasing prevalence of genetic disorders, increasing awareness among the people, and government initiatives. According to Alzheimer's Disease International, in 2015, 23 million people in the Asia-Pacific region had dementia, and by 2050 the number is expected to rise to 71 million.

The Middle East and Africa have the smallest share of the global microarray analysis market due to low funding in medical and healthcare research. However, the increasing prevalence of genetic diseases and the increase in healthcare spending favor the growth of the market in this region.

Significant Market Trends:

Reported the largest market share in the consumer goods segment in 2019

The consumables segment held a major share of the global microarray market in 2019. Repeated use and bulk purchases are the main contributors to consumables' highest market share. Factors such as new product launches are expected to maintain the dominance of consumables in the near future.

Software & Services is expected to grow at the highest CAGR during the forecast period, mainly because of the integration of software into systems.

DNA microarrays dominate market returns

DNA microarrays have multiple applications in gene expression investigations, genotyping, and transcription factor binding investigations. Oral medications are usually the first-line treatment prescribed by a doctor.

Protein microarrays scale at the highest CAGR during the forecast period. Protein microarrays characteristically consist of a number of support surfaces such as slides, nitrocellulose membranes, beads, and microtiter plates that induce protein binding. Increasing acceptance of protein microarrays for drug discovery and toxicology analysis by leading biopharmaceutical and pharmaceutical companies is expected to further propel the industry growth. 

Microarray Market report scope:

Report Attribute	Details
Study Period	2017-2030
Base Year	2022
Estimated year	2023
Forecast period	2023-2030
Historic Period	2017-2022
Units	Value (USD Billion)
Growth Rate	CAGR of 6.04% from 2023 to 2030
By Type	DNA Microarrays MM Chips Protein Microarrays Peptide Microarrays Tissue Microarrays Cellular Microarrays Other
By Product:	Consumables  Software and services  Instruments
By End-Use:	Research & Academic Institutes Pharmaceutical & Biotechnology Companies  Diagnostic Laboratories  Other End Users
By Application:	Drug Discovery Diagnostics Genomic Proteomics Other
By Companies	Thermo Fisher Scientific,  Agilent, Sequenom, Roche NimbleGen, Illumnia, Applied Microarrays, BioMerieux  SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences, ProteoGenix, And Others.
	North America US Canada Mexico Rest of North America Europe Germany France Italy Spain UK Nordic Countries Denmark Finland Iceland Sweden Norway Benelux Union Belgium The Netherlands Luxembourg Rest of Europe Asia-Pacific Japan China India Australia South Korea Southeast Asia Indonesia Thailand Malaysia Singapore Rest of Southeast Asia Rest of Asia-Pacific The Middle East & Africa Saudi Arabia UAE Egypt South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America
Reasons to Purchase this Report	Qualitative and quantitative analysis of the market based on segmentation involving both economic and non-economic factors; Provision of market value (USD Billion) data for each segment and sub-segment; Indicates the region and segment that is expected to witness the fastest growth and dominate the market; Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the market's dominance by region; Analysis by product/service type A competitive landscape that includes the market ranking of the top competitors, as well as new service/product launches, collaborations, business expansions, and acquisitions of companies featured during the previous five years Extensive company profiles with business overview, company insights, product benchmarking, and SWOT analysis for the leading market players The current and future market outlook of the industry in light of recent developments (which include growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions) Includes in-depth analysis of the market from multiple perspectives using Porter's five forces analysis Provides market insight across the Value Chain Market dynamics situation, as well as development potential for the market in the coming years 6-month post-sale analyst assistance

Key Takeaways from this Microarray Report

• The growing interest in Microarray Market over the next few years is due to the increasing application in cancer disease diagnosis as well as drug discovery.
• Business expansion and acquisitions have been the key sustainability strategies adopted by market players to ensure the growth of the Microarray Market.
• Europe region is estimated to record the fastest growth rate during the forecast period.